By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MabVax Therapeutics, Inc. 

11588 Sorrento Valley Road
Suite 20
San Diego  California  92121  U.S.A
Phone: 858-259-9405 Fax:



Company News
MabVax Therapeutics, Inc. Enters Into Exchange Agreements To Issue Common Stock And Series D Preferred Stock Eliminating Series A-1 And B Convertible Preferred And Related Warrants 3/26/2015 6:23:04 AM
MabVax Therapeutics, Inc. To Present At The 27th Annual Roth Conference 3/3/2015 10:35:31 AM
MabVax Therapeutics, Inc. Selected To Present At 2015 Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2015 11:16:22 AM
MabVax Therapeutics, Inc. Selected To Make Corporate Presentation At January 2015 BIOTECH Showcase 12/11/2014 8:30:07 AM
MabVax Therapeutics, Inc. And Memorial Sloan-Kettering Cancer Center Report On Potential Use Of Dual-Labeled Antibody To Detect And Guide Surgical Removal Of Pancreatic Cancer 11/19/2014 3:59:46 PM
MabVax Therapeutics, Inc. Launches Online Corporate Communication Channels And New Website 10/23/2014 8:48:21 AM
MabVax Therapeutics, Inc. Nominates The Fully Human Antibody HuMab 5B1 As The Company's Lead Clinical Development Candidate 10/21/2014 9:16:20 AM
MabVax Therapeutics, Inc. Announces Stock Ticker Symbol Change To MBVX 10/10/2014 9:20:26 AM
MabVax Therapeutics, Inc. Receives Orphan Drug Designation For Therapeutic Vaccine To Treat Childhood Cancer Neuroblastoma 9/25/2014 7:43:59 AM
MabVax Therapeutics, Inc. Enters Agreements With Memorial Sloan-Kettering Cancer Center And Juno Therapeutics For Development Of Anti-Cancer Therapeutics 9/10/2014 8:14:07 AM